Central VetPharma Consultancy ApS: Financial statements 2022
CVR: 38773984
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Central VetPharma Consultancy ApS (CVR 38773984) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,407,207 and a net result of DKK -97,167 compared with DKK 576,514 the year before. That is an increase of 10.4% compared with the year before. Equity in the 2022 report amounted to DKK 3,425,639. The solvency ratio was 92.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,407,207
- Profit/Loss
- DKK -97,167
- Equity
- DKK 3,425,639
- Total Assets
- DKK 3,711,160
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.4M | -97K | 3.4M | 1 |
| 2021 | - | 1.3M | 577K | 3.6M | 1 |
| 2020 | - | 1.5M | 1M | 3.2M | - |
| 2019 | - | 1.8M | 1M | 2.3M | - |
| 2018 | - | 1.4M | 543K | 1.3M | - |
Official annual report
Keep an eye on Central VetPharma Consultancy ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Central VetPharma Consultancy ApS has published its annual report for 2021. Gross profit came to DKK 1,274,445, and the net result was DKK 576,514.
About Central VetPharma Consultancy ApS
Central VetPharma Consultancy ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Elisabeth Houlberg Holm. The company is owned by Anja Elisabeth Houlberg Holm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,620,579 and a net result of DKK 719,033 compared with DKK 479,115 the year before. Equity in the 2025 report amounted to DKK 4,658,412.